Teva Pharmaceutical Industries Ltd Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment - Conference call
Monday, August 1, 2011 8:30 a.m. ET  

Event Details
TitleTeva Pharmaceutical Industries Ltd Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment - Conference call
Date and TimeMonday, August 1, 2011 8:30 a.m. ET